On the other hand, miR-101 inhibited cholangiocarcinoma angiogenesis by the direct targeting of the VEGF mRNA 3’ untranslated region and by the repression of VEGF gene transcription through the inhibition of COX-2 [35]. This evidence concerns the gene VEGFA and cholangiocarcinoma.